financetom
Business
financetom
/
Business
/
Oklo plans Tennessee plant to recycle nuclear waste
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Oklo plans Tennessee plant to recycle nuclear waste
Sep 4, 2025 12:21 PM

WASHINGTON, Sept 4 (Reuters) - Nuclear power company

Oklo ( OKLO ) said on Thursday it plans to design, build, and

operate a plant in Tennessee to recycle nuclear waste as the

first phase of a nuclear fuel center that will cost up to $1.68

billion.

If successful, the fuel plant, which requires Nuclear

Regulatory Commission approval, would be the first of its kind

in the U.S. It aims to operate by the early 2030s and create

more than 800 jobs.

The initial investment, the amount of which Oklo ( OKLO ) did not

detail, will be for the construction of a facility to recycle,

or re-process nuclear waste, which the industry calls spent

nuclear fuel, into fuel for fast reactors like Oklo's ( OKLO ) planned

Aurora reactor.

Oklo ( OKLO ) hopes to get a license from the NRC for the reactor in late

2027.

Oklo ( OKLO ) plans to work with the federally-owned Tennessee Valley

Authority utility, to recycle its nuclear waste and to evaluate

power sales from Oklo ( OKLO ) reactors to TVA.

"By recycling used fuel at scale, we are turning waste into

gigawatts, reducing costs, and establishing a secure U.S. supply

chain," said Jacob DeWitte, Oklo ( OKLO ) co-founder and CEO.

Many non-proliferation advocates oppose re-processing,

saying its supply chain could be a target for militants seeking

to seize materials for use in a crude nuclear bomb.

France and other countries have reprocessed nuclear waste by

breaking it down into uranium and plutonium and reusing those to

make new reactor fuel.

Former President Gerald Ford halted re-processing in 1976,

citing proliferation concerns. Former President Ronald Reagan

lifted a moratorium in 1981, but high costs have prevented

plants from opening.

DeWitte said plutonium and uranium separated from the waste in

Oklo's ( OKLO ) process would not be pure, but mixed with other

ingredients, making it unusable as fissile material.

Oklo ( OKLO ) said recycling the waste, now held at U.S. nuclear

reactor sites, would unlock the energy equivalent to five times

the oil reserves of Saudi Arabia.

"The next generation of nuclear technologies are being built and

developed right here in our own backyard," said TVA President

and CEO Don Moul.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BWX Technologies Plans $1 Billion Convertible Notes Offering
BWX Technologies Plans $1 Billion Convertible Notes Offering
Nov 5, 2025
10:29 AM EST, 11/05/2025 (MT Newswires) -- BWX Technologies ( BWXT ) said Wednesday it plans to offer $1 billion of convertible senior notes due 2030. Initial purchasers will be given an option to buy up to an additional $150 million of the notes. The company said it plans to use part of the net proceeds to back the cost...
Form 8.3
Form 8.3
Nov 5, 2025
LONDON--(BUSINESS WIRE)--   Ap27 FORM 8.3 IRISH TAKEOVER PANEL OPENING POSITION DISCLOSURE/DEALING DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE 1. KEY INFORMATION (a) Full name of discloser Millennium International Management LP (b) Owner or controller of interests and short positions disclosed, if...
Arch Biopartners Expands Phase II Cardiac Surgery-Associated AKI Trial to Include Royal Columbian Hospital in British Columbia
Arch Biopartners Expands Phase II Cardiac Surgery-Associated AKI Trial to Include Royal Columbian Hospital in British Columbia
Nov 5, 2025
10:30 AM EST, 11/05/2025 (MT Newswires) -- Arch Biopartners ( ACHFF ) announced Wednesday that the Fraser Health Research Ethics Board granted approval for the Royal Columbian Hospital (RCH) to participate in the company's ongoing Phase II trial evaluating LSALT peptide for the prevention and treatment of cardiac surgery-associated acute kidney injury (CS-AKI). The company said the clinical team at...
MARA Holdings Stock Climbs Despite Mixed Q3 Results: What You Need To Know
MARA Holdings Stock Climbs Despite Mixed Q3 Results: What You Need To Know
Nov 5, 2025
Shares of MARA Holdings Inc ( MARA ) are trading higher Wednesday morning, showing resilience after the company released mixed third-quarter earnings. Here’s what investors need to know. MARA is among today’s top performers. Check the market position here. What To Know: MARA Holdings ( MARA ) posted earnings per share of 27 cents, missing the consensus estimate of 44...
Copyright 2023-2026 - www.financetom.com All Rights Reserved